News
US flu activity declined steadily again last week, with rates of influenza-like illness (ILI) dropping further and staying ...
US hospital data from 2018 through 2022 shows carbapenem-resistant Acinetobacter baumanii accounted for more than one third of all Acinetobacter nfections.
As the prospect of sector-specific tariffs under the second Trump administration continues to rattle drugmakers, a more ...
One of the FDA’s recently departed top officials is weighing in on the wide-ranging staff cuts at the agency and how they ...
The HHS chief, who has long argued that vaccines cause autism, dismissed the notion that "better diagnoses, better recognition, or changing diagnostic criteria" are driving up figures. Also, the CDC's ...
Pfizer Inc.'s stock is trading at $22 with an 8% dividend yield, driven by market fears over losing vaccine revenues. Read ...
The advisory committee, which met Tuesday for the first time since Robert F. Kennedy Jr. was sworn in as health secretary, ...
In the wake of unprecedented workforce cuts at the FDA, former Commissioner Scott Gottlieb and an unnamed former CBER ...
An advisory panel on vaccines meets, carefully, in the shadow of a health secretary who has often criticized it.
As in previous studies, the SHIELD study found health care workers who received the Novavax vaccine reported significantly ...
Novavax (NVAX) announced preliminary results from the SHIELD-Utah study that showed Novavax’s COVID-19 Vaccine, Adjuvanted 2024-2025 Formula ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results